Hantavirus global briefing — August 11, 2026: Galicia clears its patient, but 42-day contact monitoring continues

Executive read

The most important change since the last briefing is in Galicia, Spain: the Franco-Argentine traveller who had tested positive for Andes hantavirus in France has been discharged after a follow-up PCR returned negative. His two close family contacts also tested negative, but they remain in home isolation under the 42-day protocol. The update narrows the immediate response; it does not turn the earlier positive result into a non-event, and it does not establish any onward transmission in Galicia. 1 2

Chile remains the more consequential severity signal. The latest readable national balance still reports 46 confirmed infections and 18 deaths through 28 July. A separate local report says the ISP confirmed Andes virus in an 11-year-old from Rengo who died in hospital, but it does not say that the national table has been revised to include her. The case-level signal is therefore clearer than the denominator. 3 4

WHO still considers the M/V Hondius outbreak over at 13 cases and three deaths. ECDC’s latest CDTR, covering 1–7 August, lists no hantavirus item in its issue summary. The latest hantavirus-specific CDC HAN page retrieved in this pass is still the 18 May testing update, which is a historical US status boundary, not a current US case count. 5 6 7

Signal	Latest verified position	What changes the watch today
Galicia, Spain	Previously positive Franco-Argentine traveller discharged after a negative PCR; two family contacts also negative but still isolated for 42 days from 28 July. 1 2	Follow-up remains necessary, but there is no verified Galicia transmission chain or additional local contact group.
Chile national	46 cases and 18 deaths through 28 July; preventive alert across 13 of 16 regions. The ministry describes the disease as endemic and not currently an epidemic. 3 4	Do not add the Rengo death to the national denominator until a revised Minsal/ISP table or direct clarification appears.
Rengo, O’Higgins	ISP confirmation is reported for an 11-year-old who died after hospitalisation; the accessible report identifies Andes virus but does not reconcile the case with the national total. 3	The diagnosis is confirmed at case level; exposure classification and denominator membership remain separate questions.
Aysén, Chile	Five confirmed infections have been reported in 2026; the two newest patients were transferred to Hospital Grant Benavente in Concepción. 8	Watch care demand and outcomes, not just case totals. The report does not demonstrate a person-to-person cluster.
WHO / ECDC / CDC	WHO’s ship-linked event is closed; ECDC week 32 names no hantavirus topic; CDC’s latest specific HAN update is dated 18 May. 5 6 7	No new escalation is verified in these official source boundaries; the coverage does not prove zero infections elsewhere.

Spain: a narrower response, not a new transmission signal

The Galicia update is operationally useful because it separates three statuses that are easy to collapse into one headline: the original positive test, the patient’s current clinical and laboratory follow-up, and the contacts’ remaining precautionary period.

The traveller had sought care in France on 23 July for relatively mild symptoms and later travelled to Galicia while asymptomatic. After a positive hantavirus result obtained in France, he was isolated with two close family contacts. On 10 August, Spanish reporting based on health-service sources said his follow-up PCR was negative, he had been discharged, and he had begun the journey back to his place of origin. The two contacts also tested negative. 1 2

The contacts were not released with the patient. Their 42-day protocol is counted from 28 July, and the reports say the two remain isolated despite negative PCR results. Galicia’s public-health officials had also said that no further contacts had been identified in the region. French authorities were tracing the traveller’s route through Nouvelle-Aquitaine, Normandy, and Île-de-France, where people classified as high-risk contacts were to follow a six-week home-isolation protocol. 2

For risk assessment, the negative follow-up results lower the immediate concern around the Galicia household. They do not support a claim that the original positive was false, nor do they change the separate WHO conclusion that the M/V Hondius outbreak was over. The current signal is a contained imported-case response with continued precautionary follow-up, not evidence of a new Spanish cluster. 5

Chile: the case signal is ahead of the denominator

The Rengo report provides a confirmed case-level development but no clean national update. Diarios en Red says the ISP confirmed Andes virus in an 11-year-old resident of Rengo who died after hospitalisation in Rancagua. The same report continues to cite the latest official national balance as 46 cases and 18 deaths through 28 July. It does not state that the new death was added to that total. 3

UPI’s report of the Ministry of Health alert gives the operational context for that baseline. The alert covers 13 of Chile’s 16 regions and is intended to strengthen epidemiological surveillance, resource management, specialist hiring, health controls, and direct procurement. The ministry’s public-health leadership described hantavirus as endemic and said the situation was not currently considered an epidemic. 4

That distinction matters for the daily watch. A confirmed diagnosis can be a new case-level signal while the national denominator remains unchanged because the case may already be included, may fall outside the table’s reporting period, or may still await formal reconciliation. Until Minsal or ISP publishes that reconciliation, the defensible position is confirmed Rengo case, unrevised 46/18 national baseline.

Aysén shows why care capacity belongs beside the count. A 6 August report recorded five confirmed infections in the region during 2026 and said the two newest patients were being treated at Hospital Grant Benavente in Concepción after transfer from Aysén. The same report repeated practical precautions: seal rodent entry points, store food in closed containers, use protection for forestry, foraging, and cleaning work, ventilate rodent-contaminated rooms for 20–30 minutes, and clean with a chlorine solution rather than dry sweeping. These measures target rodent exposure; the report does not describe a human-to-human chain. 8

Official status boundaries: what has and has not moved

WHO. WHO’s 2 July remarks remain the clearest closure record for the M/V Hondius event: no further cases had been reported since 25 May, the last contact completed quarantine and tested negative, and the outbreak was considered over at 13 cases, including three deaths. More than 650 contacts had been followed in 33 countries and territories. The Galicia case should not be folded into that count without a documented epidemiological or genomic link. 5

ECDC. The latest CDTR page was published on 7 August and covers 1–7 August. Its issue summary names Ebola, chikungunya, dengue, West Nile virus infection, Crimean-Congo haemorrhagic fever, Vibrio, respiratory-virus epidemiology, World Pride, MERS, and expert deployments; hantavirus is not named. This is a bounded statement about that bulletin, not a claim that Europe had zero hantavirus infections. 6

CDC. CDC HAN-00529, dated 18 May, reported no confirmed US Andes-virus cases associated with the cruise outbreak as of that date and described the overall public risk as extremely low at the time. It also instructed clinicians to consider Andes virus in compatible illness after exposure to the ship or its contacts, and to consider other hantaviruses after rodent exposure. Because no newer hantavirus-specific HAN update was verified here, this page should not be used as a current US surveillance total. 7

Across these three sources, the official posture has not escalated since the last briefing. The new Spanish follow-up changes a national response detail; it does not create a new WHO-level event. No new authoritative case denominator in Asia-Pacific or another region was verified within this edition’s 10 August 08:00 to 11 August 08:00 (+08:00) monitoring window. That absence is a coverage boundary, not evidence of no infections.

Research digest: what a new pediatric review changes for care watchpoints

Hantavirus Infections in Children

Authors and source: Calvin J. Cable and Walter Dehority, Vanderbilt University School of Medicine; Pediatrics in Review, 47(8), 429–438; published 1 August 2026. DOI: 10.1542/pir.2025-006862. 9
Study type and evidence strength: Narrative review. PubMed classifies it as a review/journal article; it is not a cohort, clinical trial, or new surveillance series. No study sample size, confidence interval, or treatment effect estimate is reported in the record. 9
What it adds: The review distinguishes New World hantavirus cardiopulmonary syndrome, which it says can kill up to one-third of affected patients, from Old World hemorrhagic fever with renal syndrome, for which mortality can reach 15% depending on the virus. It emphasizes that children may present with a nonspecific viral prodrome, can deteriorate rapidly, and should be recognized early and transferred to tertiary care when severe disease is suspected. It also identifies access to ventilation, dialysis, cardiovascular monitoring, and ECMO as part of the supportive-care capacity that can affect outcomes. 9
Why it matters here: The paper does not revise Chile’s case count or explain the Rengo death. Its practical value is narrower: it gives a care-capacity lens for a briefing that is already tracking a fatal pediatric case and transfers from Aysén to a tertiary hospital.
Limitations: The article is a clinical review rather than new patient-level evidence. Its mortality ranges are broad background figures, not estimates for Chile in 2026, and the abstract does not provide a formal systematic-review method or a new pediatric denominator. It should guide clinical attention, not be used to infer the severity of the current Chilean cluster.

A second research point is negative by design: no new peer-reviewed or preprint hantavirus study published inside this edition’s 24-hour window was verified. The pediatric review is included because it was published in the current August literature and adds a care-capacity dimension not present in the new Spain case report; it is labeled as background rather than as a new outbreak measurement.

Reservoir and exposure watch

The available Chilean reporting continues to point to the long-tailed pygmy rice rat and contaminated rural or semi-rural environments as the main exposure context. UPI’s quoted specialists linked risk to rodent food availability, rainfall patterns, vegetation cycles, outdoor activity, and settlement expansion, while also stressing that these are interacting environmental factors rather than a single demonstrated cause of the 2026 fatality snapshot. 4

No new rodent-abundance survey, reservoir infection estimate, or environmental sampling result was verified in the 10–11 August window. The operational advice from Aysén is therefore more actionable than any claim about a new ecological driver: reduce contact with rodent excreta, ventilate before cleaning, and use wet disinfection rather than dry sweeping. 8

Watchpoints for the next briefing

Galicia and France: whether the two Spanish contacts complete the 42-day protocol without symptoms or a positive follow-up test, and whether French tracing identifies any additional high-risk contacts.
Chile’s denominator: whether Minsal or ISP publishes a revised table that explicitly includes or excludes the confirmed Rengo death.
Aysén care demand: outcomes for the two transferred patients, any new severe cases, and any change in the regional total of five confirmed infections.
Official escalation: a new WHO Disease Outbreak News item, an ECDC bulletin that explicitly names hantavirus, or a current CDC Andes-virus update.
Reservoir evidence: a field survey or laboratory report that can distinguish a measured rodent signal from broad environmental hypotheses.
Clinical research: new primary data on pediatric outcomes, diagnostics, supportive care, or Andes-virus transmission—not another general background review alone.

Bottom line

Galicia’s imported-case response has moved into a lower-intensity phase: the previously positive traveller is discharged after a negative follow-up PCR, and his two close contacts are also PCR-negative. The contacts remain isolated because the protocol is driven by exposure timing, not by one negative test. There is no verified Galicia transmission chain.

Chile’s situation remains harder to summarize than its headline. Rengo is a confirmed case-level signal, while the latest readable national denominator remains 46 infections and 18 deaths through 28 July. Aysén’s five-case regional total and hospital transfers keep care capacity in view. WHO’s ship-linked outbreak remains closed, and no new WHO, CDC, or ECDC escalation is verified in this pass.